These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38362632)

  • 21. Clinical Guideline Highlights for the Hospitalist: Therapeutic Monitoring of Vancomycin.
    Murphy M; Girdwood ST; Scheetz MH
    J Hosp Med; 2020 Dec; 15(12):740-742. PubMed ID: 33231544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quality standard for the treatment of bacteremia. The Infectious Diseases Society of America.
    Gross PA; Barrett TL; Dellinger EP; Krause PJ; Martone WJ; McGowan JE; Sweet RL; Wenzel RP
    Infect Control Hosp Epidemiol; 1994 Mar; 15(3):189-92. PubMed ID: 8207177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical infectious diseases pharmacists in the United States: a problem of both supply and demand.
    Gauthier TP; Worley M; Laboy V; Hernandez L; Unger NR; Sherman EM; Frederick C; Aragon L
    Clin Infect Dis; 2015 Mar; 60(5):826-7. PubMed ID: 25409474
    [No Abstract]   [Full Text] [Related]  

  • 24. European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine).
    Paul M; Carrara E; Retamar P; Tängdén T; Bitterman R; Bonomo RA; de Waele J; Daikos GL; Akova M; Harbarth S; Pulcini C; Garnacho-Montero J; Seme K; Tumbarello M; Lindemann PC; Gandra S; Yu Y; Bassetti M; Mouton JW; Tacconelli E; Rodríguez-Baño J
    Clin Microbiol Infect; 2022 Apr; 28(4):521-547. PubMed ID: 34923128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases.
    Gupta K; Hooton TM; Naber KG; Wullt B; Colgan R; Miller LG; Moran GJ; Nicolle LE; Raz R; Schaeffer AJ; Soper DE; ;
    Clin Infect Dis; 2011 Mar; 52(5):e103-20. PubMed ID: 21292654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Engaging Pharmacy Students, Residents, and Fellows in Antimicrobial Stewardship.
    Chahine EB; El-Lababidi RM; Sourial M
    J Pharm Pract; 2015 Dec; 28(6):585-91. PubMed ID: 24399574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Strategies to enhance rational use of antibiotics in hospital: a guideline by the German Society for Infectious Diseases.
    de With K; Allerberger F; Amann S; Apfalter P; Brodt HR; Eckmanns T; Fellhauer M; Geiss HK; Janata O; Krause R; Lemmen S; Meyer E; Mittermayer H; Porsche U; Presterl E; Reuter S; Sinha B; Strauß R; Wechsler-Fördös A; Wenisch C; Kern WV
    Infection; 2016 Jun; 44(3):395-439. PubMed ID: 27066980
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Applicability of American College of Clinical Pharmacy (ACCP) competencies to clinical pharmacy practice in Egypt.
    Elmaaty MA; Elberry AA; Hussein RR; Khalil DM; Khalifa AE
    Pharm Pract (Granada); 2020; 18(3):1951. PubMed ID: 33005259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antimicrobial de-escalation in critically ill patients: a position statement from a task force of the European Society of Intensive Care Medicine (ESICM) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Critically Ill Patients Study Group (ESGCIP).
    Tabah A; Bassetti M; Kollef MH; Zahar JR; Paiva JA; Timsit JF; Roberts JA; Schouten J; Giamarellou H; Rello J; De Waele J; Shorr AF; Leone M; Poulakou G; Depuydt P; Garnacho-Montero J
    Intensive Care Med; 2020 Feb; 46(2):245-265. PubMed ID: 31781835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Position Paper on Critical Care Pharmacy Services (Executive Summary): 2020 Update.
    Lat I; Paciullo C; Daley MJ; MacLaren R; Bolesta S; McCann J; Stollings JL; Gross K; Foos SA; Roberts RJ; Acquisto NM; Taylor S; Bentley M; Jacobi J; Meyer TA
    Am J Health Syst Pharm; 2020 Sep; 77(19):1619-1624. PubMed ID: 32814962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summary.
    Floto RA; Olivier KN; Saiman L; Daley CL; Herrmann JL; Nick JA; Noone PG; Bilton D; Corris P; Gibson RL; Hempstead SE; Koetz K; Sabadosa KA; Sermet-Gaudelus I; Smyth AR; van Ingen J; Wallace RJ; Winthrop KL; Marshall BC; Haworth CS
    Thorax; 2016 Jan; 71(1):88-90. PubMed ID: 26678435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Guidelines for evaluation of new fever in critically ill adult patients: 2008 update from the American College of Critical Care Medicine and the Infectious Diseases Society of America.
    O'Grady NP; Barie PS; Bartlett JG; Bleck T; Carroll K; Kalil AC; Linden P; Maki DG; Nierman D; Pasculle W; Masur H; ;
    Crit Care Med; 2008 Apr; 36(4):1330-49. PubMed ID: 18379262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A survey of the utilization of anti-pseudomonal beta-lactam therapy in cystic fibrosis patients.
    Zobell JT; Young DC; Waters CD; Ampofo K; Cash J; Marshall BC; Olson J; Chatfield BA
    Pediatr Pulmonol; 2011 Oct; 46(10):987-90. PubMed ID: 21520438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: Guidelines for the management of hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociación Latinoamericana del Tórax (ALAT).
    Torres A; Niederman MS; Chastre J; Ewig S; Fernandez-Vandellos P; Hanberger H; Kollef M; Li Bassi G; Luna CM; Martin-Loeches I; Paiva JA; Read RC; Rigau D; Timsit JF; Welte T; Wunderink R
    Eur Respir J; 2017 Sep; 50(3):. PubMed ID: 28890434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Executive Summary of the Consensus Statement of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), the Spanish Society of Tropical Medicine and International Health (SEMTSI), the Spanish Association of Surgeons (AEC), the Spanish Society of Pneumology and Thoracic Surgery (SEPAR), the Spanish Society of Thoracic Surgery (SECT), the Spanish Society of Vascular and Interventional Radiology (SERVEI), and the Spanish Society of Paediatric Infectious Diseases (SEIP), on the Management of Cystic Echinococcosis.
    Belhassen-Garcia M; Balboa Arregui Ó; Calabuig-Muñoz E; Carmena D; Esteban Velasco MDC; Fuentes Gago M; Fumado Pérez V; García Alonso J; García López Hortelano M; González Fernández LM; Herrero Martínez JM; Iglesias Iglesias MJ; Jiménez López M; López-Vélez R; Muñoz-Bellvis L; Muro A; Pardo-Lledías J; Peñaranda-Vera M; Perteguer-Prieto MJ; Picado A; Quiñones Sampedro JE; Rodríguez-Guardado A; Royo Crespo Í; Salvador F; Sánchez-Montalvá A; Torrús Tendero D; Velasco Pelayo L
    Enferm Infecc Microbiol Clin (Engl Ed); 2020; 38(6):283-288. PubMed ID: 31866064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Understanding the expanding role of pharmacy services in outpatient cystic fibrosis care.
    Zobell JT; Moss J; Heuser S; Roe L; Young DC
    Pediatr Pulmonol; 2021 Jun; 56(6):1378-1385. PubMed ID: 33470556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Point-of-care testing for infectious diseases: opportunities, barriers, and considerations in community pharmacy.
    Gubbins PO; Klepser ME; Dering-Anderson AM; Bauer KA; Darin KM; Klepser S; Matthias KR; Scarsi K
    J Am Pharm Assoc (2003); 2014; 54(2):163-71. PubMed ID: 24632931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper
    Abdul-Aziz MH; Alffenaar JC; Bassetti M; Bracht H; Dimopoulos G; Marriott D; Neely MN; Paiva JA; Pea F; Sjovall F; Timsit JF; Udy AA; Wicha SG; Zeitlinger M; De Waele JJ; Roberts JA; ; ; ;
    Intensive Care Med; 2020 Jun; 46(6):1127-1153. PubMed ID: 32383061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Building an Antimicrobial Stewardship Program: Cooperative Roles for Pharmacists, Infectious Diseases Specialists, and Clinical Microbiologists.
    Kim J; Craft DW; Katzman M
    Lab Med; 2015; 46(3):e65-71. PubMed ID: 26283698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Infectious Diseases Society of America position statement on infectious diseases physicians and hospital pharmacists: comment and editorial.
    Quintiliani R; Ambrose PG; Nicolau DP; Richerson MA; Bui KQ; McNabb J; Nightingale CH; Owens RC
    Clin Infect Dis; 1998 Jul; 27(1):229-31. PubMed ID: 9675493
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.